CD4 testing after initiation of antiretroviral therapy: Analysis of routine data from the South African HIV programme

Background: People living with HIV (PLHIV) who have low CD4 counts require advanced clinical care (ACC) to minimise morbidity and mortality risk. These patients include immunological non-responders (INRs) with low CD4 counts despite a suppressed viral load. Objectives: To determine the proportion o...

Full description

Bibliographic Details
Main Authors: Rivka R. Lilian, Natasha Davies, Louise Gilbert, James A. McIntyre, Helen E. Struthers, Kate Rees
Format: Article
Language:English
Published: AOSIS 2020-12-01
Series:Southern African Journal of HIV Medicine
Subjects:
Online Access:https://sajhivmed.org.za/index.php/hivmed/article/view/1165
_version_ 1828198635257462784
author Rivka R. Lilian
Natasha Davies
Louise Gilbert
James A. McIntyre
Helen E. Struthers
Kate Rees
author_facet Rivka R. Lilian
Natasha Davies
Louise Gilbert
James A. McIntyre
Helen E. Struthers
Kate Rees
author_sort Rivka R. Lilian
collection DOAJ
description Background: People living with HIV (PLHIV) who have low CD4 counts require advanced clinical care (ACC) to minimise morbidity and mortality risk. These patients include immunological non-responders (INRs) with low CD4 counts despite a suppressed viral load. Objectives: To determine the proportion of patients with low CD4 counts after antiretroviral therapy (ART) initiation and to describe INRs within that group. Methods: Routine Three Interlinked Electronic Registers.Net (TIER.Net) data from four South African districts were analysed for adult PLHIV on ART 12 months. Immunological non-responders were defined as patients on ART 4 years who were virally suppressed (viral load 1000 copies/mL) with a CD4 count ≤ 350 cell/mm3. Results: Baseline CD4 was recorded for 80.9% of the 869 571 patients newly initiating ART, with 37.2% of those starting ART since 2017 having baseline counts ≤ 200 cells/mm3. Amongst all 1 178 190 patients on ART, only 46.5% had a CD4 test after ART initiation and of these, 14.3% had CD4 ≤ 200 cells/mm3. This proportion was highest amongst patients on ART ≤ 2 years (19.7%) (p 0.001). Amongst virally suppressed patients, 20.0% were INRs. Immunological non-response was significantly more likely amongst patients on second-line ART (adjusted odds ratio [aOR] 1.79), those aged 35-45 and ≥ 45 years (aOR 1.15 and 1.50, respectively), males (aOR 2.28) and patients with confirmed TB (aOR 2.49), and was significantly less likely in cases with higher baseline CD4 count (aOR 0.35). Conclusion: CD4 testing subsequent to ART initiation is poorly implemented and there is a notable proportion of patients with low CD4 counts. Guidelines regarding CD4 testing and ACC need to be more widely implemented to identify patients with low CD4 counts and improve their outcomes.
first_indexed 2024-04-12T10:41:42Z
format Article
id doaj.art-a0c94b2a87554e38a24835fdf7b406c2
institution Directory Open Access Journal
issn 1608-9693
2078-6751
language English
last_indexed 2024-04-12T10:41:42Z
publishDate 2020-12-01
publisher AOSIS
record_format Article
series Southern African Journal of HIV Medicine
spelling doaj.art-a0c94b2a87554e38a24835fdf7b406c22022-12-22T03:36:35ZengAOSISSouthern African Journal of HIV Medicine1608-96932078-67512020-12-01211e1e410.4102/sajhivmed.v21i1.1165718CD4 testing after initiation of antiretroviral therapy: Analysis of routine data from the South African HIV programmeRivka R. Lilian0Natasha Davies1Louise Gilbert2James A. McIntyre3Helen E. Struthers4Kate Rees5Anova Health Institute, JohannesburgAnova Health Institute, JohannesburgAnova Health Institute, JohannesburgAnova Health Institute, Johannesburg, South Africa; and, School of Public Health and Family Medicine, University of Cape Town, Cape TownAnova Health Institute, Johannesburg, South Africa; and, Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Cape TownAnova Health Institute, Johannesburg, South Africa; and, Department of Community Health, School of Public Health, University of the Witwatersrand, JohannesburgBackground: People living with HIV (PLHIV) who have low CD4 counts require advanced clinical care (ACC) to minimise morbidity and mortality risk. These patients include immunological non-responders (INRs) with low CD4 counts despite a suppressed viral load. Objectives: To determine the proportion of patients with low CD4 counts after antiretroviral therapy (ART) initiation and to describe INRs within that group. Methods: Routine Three Interlinked Electronic Registers.Net (TIER.Net) data from four South African districts were analysed for adult PLHIV on ART 12 months. Immunological non-responders were defined as patients on ART 4 years who were virally suppressed (viral load 1000 copies/mL) with a CD4 count ≤ 350 cell/mm3. Results: Baseline CD4 was recorded for 80.9% of the 869 571 patients newly initiating ART, with 37.2% of those starting ART since 2017 having baseline counts ≤ 200 cells/mm3. Amongst all 1 178 190 patients on ART, only 46.5% had a CD4 test after ART initiation and of these, 14.3% had CD4 ≤ 200 cells/mm3. This proportion was highest amongst patients on ART ≤ 2 years (19.7%) (p 0.001). Amongst virally suppressed patients, 20.0% were INRs. Immunological non-response was significantly more likely amongst patients on second-line ART (adjusted odds ratio [aOR] 1.79), those aged 35-45 and ≥ 45 years (aOR 1.15 and 1.50, respectively), males (aOR 2.28) and patients with confirmed TB (aOR 2.49), and was significantly less likely in cases with higher baseline CD4 count (aOR 0.35). Conclusion: CD4 testing subsequent to ART initiation is poorly implemented and there is a notable proportion of patients with low CD4 counts. Guidelines regarding CD4 testing and ACC need to be more widely implemented to identify patients with low CD4 counts and improve their outcomes.https://sajhivmed.org.za/index.php/hivmed/article/view/1165cd4hivsouth africaadvanced clinical careimmunological non-respondertier.net
spellingShingle Rivka R. Lilian
Natasha Davies
Louise Gilbert
James A. McIntyre
Helen E. Struthers
Kate Rees
CD4 testing after initiation of antiretroviral therapy: Analysis of routine data from the South African HIV programme
Southern African Journal of HIV Medicine
cd4
hiv
south africa
advanced clinical care
immunological non-responder
tier.net
title CD4 testing after initiation of antiretroviral therapy: Analysis of routine data from the South African HIV programme
title_full CD4 testing after initiation of antiretroviral therapy: Analysis of routine data from the South African HIV programme
title_fullStr CD4 testing after initiation of antiretroviral therapy: Analysis of routine data from the South African HIV programme
title_full_unstemmed CD4 testing after initiation of antiretroviral therapy: Analysis of routine data from the South African HIV programme
title_short CD4 testing after initiation of antiretroviral therapy: Analysis of routine data from the South African HIV programme
title_sort cd4 testing after initiation of antiretroviral therapy analysis of routine data from the south african hiv programme
topic cd4
hiv
south africa
advanced clinical care
immunological non-responder
tier.net
url https://sajhivmed.org.za/index.php/hivmed/article/view/1165
work_keys_str_mv AT rivkarlilian cd4testingafterinitiationofantiretroviraltherapyanalysisofroutinedatafromthesouthafricanhivprogramme
AT natashadavies cd4testingafterinitiationofantiretroviraltherapyanalysisofroutinedatafromthesouthafricanhivprogramme
AT louisegilbert cd4testingafterinitiationofantiretroviraltherapyanalysisofroutinedatafromthesouthafricanhivprogramme
AT jamesamcintyre cd4testingafterinitiationofantiretroviraltherapyanalysisofroutinedatafromthesouthafricanhivprogramme
AT helenestruthers cd4testingafterinitiationofantiretroviraltherapyanalysisofroutinedatafromthesouthafricanhivprogramme
AT katerees cd4testingafterinitiationofantiretroviraltherapyanalysisofroutinedatafromthesouthafricanhivprogramme